Standard Biotools (LAB) Other Working Capital Changes (2010 - 2026)

Standard Biotools (LAB) has 17 years of Other Working Capital Changes data on file, last reported at -$29.9 million in Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$29.9 million, down 7875.06% year-over-year; the trailing twelve-month figure through Mar 2026 was -$36.7 million (down 1730.29% YoY), and the FY2025 annual result was -$6.4 million, down 54.84% from the prior year.
• Other Working Capital Changes eased to -$29.9 million in Q1 2026 per LAB's latest filing, from -$5.2 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $5.0 million in Q2 2024 and troughed at -$29.9 million in Q1 2026.
• A 5-year average of -$2.5 million and a median of -$477000.0 in 2023 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes tumbled 28345.45% in 2023, then soared 1157.02% in 2024.
• A 5-year view of Other Working Capital Changes shows it stood at -$3.6 million in 2022, then soared by 201.49% to $3.7 million in 2023, then plunged by 242.54% to -$5.3 million in 2024, then rose by 0.74% to -$5.2 million in 2025, then slumped by 474.0% to -$29.9 million in 2026.
• Business Quant data shows LAB's Other Working Capital Changes at -$29.9 million in Q1 2026, -$5.2 million in Q4 2025, and $700000.0 in Q3 2025.